ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceutical Chemicals

AGC boosts active pharmaceutical ingredient production

by Jean-François Tremblay
July 22, 2018 | APPEARED IN VOLUME 96, ISSUE 30

 

AGC, formerly Asahi Glass, plans a 10-fold increase in its capacity to make active pharmaceutical ingredients and intermediates at a plant in Chiba, Japan, that complies with international regulations. The Chiba plant, which currently produces only small quantities for drug trials, will in the future be able to turn out commercial quantities. AGC says it initiated production of pharmaceutical ingredients in the 1980s by leveraging its fluorination know-how.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment